Chromosomal microarray testing influences medical management. - Wikidata - wikimedia - TriplyDB

Chromosomal microarray testing influences medical management.

Chromosomal microarray testing influences medical management.

http://www.wikidata.org/entity/Q37895879

about

Further clinical and molecular delineation of the 15q24 microdeletion syndrome Whole Genome Sequencing Expands Diagnostic Utility and Improves Clinical Management in Pediatric Medicine The clinical impact of chromosomal microarray on paediatric care in Hong Kong.Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.CNV-ROC: A cost effective, computer-aided analytical performance evaluator of chromosomal microarrays The genetics of microdeletion and microduplication syndromes: an update.A genome-wide screen for copy number alterations in an adolescent pilot cohort with müllerian anomalies.Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray Variants of unknown significance on chromosomal microarray analysis: parental perspectives.Parents' perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices Analytical and Clinical Validity Study of FirstStepDx PLUS: A Chromosomal Microarray Optimized for Patients with Neurodevelopmental Conditions.Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era Genetic testing and genetic counseling among Medicaid-enrolled children with autism spectrum disorder in 2001 and 2007.Low Rates of Genetic Testing in Children With Developmental Delays, Intellectual Disability, and Autism Spectrum Disorders.The utility of chromosomal microarray analysis in developmental and behavioral pediatrics.What Do Parents Think about Chromosomal Microarray Testing? A Qualitative Report from Parents of Children with Autism Spectrum Disorders.Utilization of genetic testing among children with developmental disabilities in the United States.Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders Sequencing-based diagnostics for pediatric genetic diseases: progress and potential Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies.De novo 393 kb microdeletion of 7p11.2 characterized by aCGH in a boy with psychomotor retardation and dysmorphic features Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder.Clinical performance of the CytoScan Dx Assay in diagnosing developmental delay/intellectual disability.Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.Current use of chromosomal microarray by Australian paediatricians and implications for the implementation of next generation sequencing.The impact of chromosomal microarray on clinical management: a retrospective analysis.Mothers' appreciation of chromosomal microarray analysis for autism spectrum disorder.Chromosomal microarray impacts clinical management.Prematurity, ventricular septal defect and dysmorphisms are independent predictors of pathogenic copy number variants: a retrospective study on array-CGH results and phenotypical features of 293 children with neurodevelopmental disorders and/or mult Chromosomal Microarray: Application for Congenital Heart Diseases.Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability.Providing family guidance in rapidly shifting sand: informed consent for genetic testing

P2860

Q28732710-D9C81688-4F72-47D5-837B-4F10648072E2 Q33736038-B9B71BF2-7C4F-4179-BC20-AAD600EC6988 Q34343633-6E2FB4EC-535C-47A2-9021-0BE1365EDA54 Q34547121-A1BE51F0-DFC5-4C7E-86D0-7096A71CF09D Q35544004-0FEFD1B6-CEFF-4FB8-87BD-AE2CCF2AC6CE Q35765523-94A021EF-8CEF-4ABB-BCFB-4DDB62E835C0 Q35768004-9E10B06E-8904-460D-892A-50A7C6AD7420 Q35877328-B1B93035-25C9-492F-9E11-D58970A88DFF Q35959752-B136661B-A97E-42A3-83A3-F6FA70E6AB5B Q36054612-F6E839EE-6A75-4ED4-92C0-09B4C3EF6259 Q36068717-B80E6CB8-14FF-42EC-8D14-D51B2B79FB3D Q36236352-67F1EA9B-A083-424E-92CD-68AB57C6263E Q36327651-6080F90F-C2D3-40C9-87B8-7C8FCC52B359 Q36380279-625EF07D-2B9A-43B3-BF88-F01D1A08D17C Q36614115-C3B586AC-6F8F-44A1-B7E0-792365BF246D Q36668794-97F2ADC3-71BA-44B1-825D-34F3682B55E5 Q37052357-0E05FD7B-1EEE-444D-9FA1-C4A23881BF8A Q37060658-F633E0F2-EF54-4BBE-9870-C1F47B6578C8 Q37098689-9382ED52-EDB6-4864-AFF2-7FF1C3EC5B57 Q37453434-CF06D3D7-2ADD-4B00-9127-156BB3D007CB Q38844223-DD9B5795-2E73-4F07-8707-9D4D5276885E Q39127499-BE833A3C-9048-442F-90C8-7B33822D530F Q41551222-776D221D-6E6B-4D72-B65F-E5AF88366B8E Q42362268-F0C1EED5-4480-46E4-B281-FC7F9F727200 Q46344675-75E61432-1839-4B9F-A2B2-4EF2BCEDFDA0 Q48267638-2B3C3A7D-048A-4D2E-8324-9FDCDB3DFE71 Q48658445-53F0247C-20AE-4D22-88A1-FD6A9CF70759 Q50308309-6A293E02-5F99-4E82-BAAC-0A6CD3366FA4 Q50310101-07CC972F-E1B5-405C-9297-87946CC3A033 Q50763347-9DEB6AE2-EC71-4CCA-86B7-3884CE858431 Q52664033-615314CA-A5B4-48CC-9427-9B9866C22AA0 Q55102159-92BF5AE8-E44F-4C05-AFFD-937D9DA699ED Q55129600-3FEDEAA9-D133-451C-9743-9A6FD423BC44 Q56772275-CD99C785-A8CA-49BF-B7E2-5334920E2122

P2860

Chromosomal microarray testing influences medical management.

http://www.wikidata.org/entity/Q37895879

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chromosomal microarray testing influences medical management.

@en

Chromosomal microarray testing influences medical management.

@nl

type

label

Chromosomal microarray testing influences medical management.

@en

Chromosomal microarray testing influences medical management.

@nl

prefLabel

Chromosomal microarray testing influences medical management.

@en

Chromosomal microarray testing influences medical management.

@nl

P1433

Q37895879-AEB4A9CF-4662-4A85-9DBA-5BDF016E5C0A

P1476

Q37895879-85E3CCE5-F404-4E61-B45E-59872DE3E02A

P2093

Q37895879-24BA86EF-B880-46BE-9E99-61E5FE78409B

Q37895879-2D035085-3DFC-41F3-8CBE-E0E085024802

Q37895879-2ECFF542-2760-4C86-99DB-C0E524C2B207

Q37895879-41F8C6B1-077C-465A-9995-9D36E948A8D9

Q37895879-5E1239C1-5726-4ADF-BAF5-46F54EA9A651

Q37895879-7CE4BAEE-974F-4C9F-8CDA-089EDCAE41FE

Q37895879-DA679B81-E265-4E53-874C-769875EA2CF0

Q37895879-E540F4B8-F440-4B1F-907F-A32BDDDFEABB

P2860

Q37895879-1C086474-8A7E-4A53-BCD4-65CF43A7946F

Q37895879-259CAEA9-994B-42F2-9479-B6C9E1DD9C33

Q37895879-347B8459-BA6E-4C73-9B4A-E1CF824ABC41

Q37895879-6A91FF04-F1F2-4B18-92EB-C87F584D9539

Q37895879-865BFB15-961C-4073-ACCF-02FC0F1E26A3

Q37895879-905FD23D-165D-4F78-85C7-6BBAFF351A15

Q37895879-97AAEA55-09DE-4AFD-B606-90FBD68AA93D

Q37895879-9EC8644C-57CC-4D1F-9AA6-ABD0CFEF43D8

Q37895879-A790006F-03E7-4367-84CB-BC8D63030DBC

Q37895879-B36EAAA0-8FD8-4600-B124-00E1BE13EBE2

P2888

Q37895879-76EDE093-FEAD-423A-937E-6042C978BD02

P304

Q37895879-6583AC9C-EEDC-4151-97F2-52EFD81459B4

P31

Q37895879-12C6C0C6-3D65-4C1C-8269-A54D60B021EC

P356

Q37895879-21D3C525-B111-418D-BEBE-9AC80A0DD8BA

P407

Q37895879-F63DAE6F-A7DD-4384-9F39-E72E18ABEAFA

P433

Q37895879-72CC5353-8886-4E0C-90E4-3F6B23B9F6F9

P478

Q37895879-CFE4CBC0-2DD6-40D2-B5D9-6DF4B3B50F09

P577

Q37895879-89830F5F-1D83-492C-BF7E-24B4B40C6BC2

P6179

Q37895879-0600AF37-8A19-4EFC-B375-64C691C1FF3B

P698

Q37895879-4BF2EDFC-71D7-4BBB-AC25-9B2F3711CA17

P356

GIM.0B013E31821DD54A

P1433

Genetics in Medicine

P1476

Chromosomal microarray testing influences medical management.

@en

P2093

Amy E Roberts

http://www.w3.org/2001/XMLSchema#string

David J Harris

http://www.w3.org/2001/XMLSchema#string

David T Miller

http://www.w3.org/2001/XMLSchema#string

Jonathan Picker

http://www.w3.org/2001/XMLSchema#string

Magdi M Sobeih

http://www.w3.org/2001/XMLSchema#string

Michael E Coulter

http://www.w3.org/2001/XMLSchema#string

Mira Irons

http://www.w3.org/2001/XMLSchema#string

Pamela Hawley

http://www.w3.org/2001/XMLSchema#string

P2860

Copy-number variations associated with neuropsychiatric conditions

Copy number variation and schizophrenia

Structural variation of chromosomes in autism spectrum disorder

Association between microdeletion and microduplication at 16p11.2 and autism

Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies

Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size

Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies

Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability.

Recurrent 16p11.2 microdeletions in autism.

P2888

gim.0b013e31821dd54a

P304

770-776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/GIM.0B013E31821DD54A

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1045362488

http://www.w3.org/2001/XMLSchema#string

P698

21716121

http://www.w3.org/2001/XMLSchema#string